Skip to content
10-K

Annual Report

INNOVATION PHARMACEUTICALS INC.

0001477932-21-006717

← back to feed
Filed
Sep 27, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Sep 22, 2021 437.1M sh
Operating Cash Flow FY 2021 · Jun 30, 2020 −$4.16M
Current Liabilities FY 2021 · Jun 30, 2020 $7.37M
Total Liabilities FY 2021 · Jun 30, 2020 $7.79M
Current Assets FY 2021 · Jun 30, 2020 $6.11M
Total Assets FY 2021 · Jun 30, 2020 $9.25M
Sga Expense FY 2021 · Jun 30, 2020 $1.43M
Rd Expense FY 2021 · Jun 30, 2020 $2.79M
Net Income FY 2021 · Jun 30, 2020 −$6.65M
Operating Income FY 2021 · Jun 30, 2020 −$4.64M
Revenue FY 2021 · Jun 30, 2020 $423K
Cash And Equivalents FY 2021 · Jun 30, 2019 $579K